What we need to know before cancer therapy. ESC 2022 Clinical Practice Guidelines - Webinar Series
8 September 2022, from
European Society of Cardiology
Doctor D. Cardinale (Milan, IT)
Professor J. Herrmann (Rochester, US)
Doctor P. Thavendiranathan (Toronto, CA)
After watching this webinar, participants will be able to:
define common cardiovascular toxicity of cancer and its therapies;
detail and summarise definitions of cardiovascular toxicities encountered during and after cancer therapy; and
assess baseline cardiovascular toxicity risk of common therapies
To fulfill an urgent need to align cardiology practices with new cardio-oncology guidelines, which will provide a skillset allowing assessment of cardiovascular toxicity risk from common cancer therapies prior to initiation of therapy.
Among other desired outcomes of the webinar:
adoption and utilisation of consensus definitions in clinical practice and research publications, thereby reducing variation and increasing direct comparability of patient care/study results; and
survey results of practicing oncologists/hematologists and cardio-oncologists about how they define cardiovascular toxicity and the application of a consensus definition over time.
See "more details" for subsequent webinar topics.
Cardiovascular Disease in Special Populations
This webinar is part of the "2022 ESC Guidelines Series on Cardio-Oncology"
The role of cardiac imaging for assessment of specific patient populations, according to new 2022 ESC Guidelines on Cardio-Oncology. A joint webinar of EACVI / ESC Council of Cardio-Oncology - January 2023 (the date will be confirmed soon)
Discover the complete ESC Education offer on the 2022 Guidelines here
This webinar is designed for general cardiologist and trainees but also cardiologists wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
The webinar is available on PC and tablets. The use of a smartphone is not recommended.